Stock Price
29.94
Daily Change
1.02 3.53%
Monthly
12.77%
Yearly
11.47%
Q3 Forecast
29.70

ALKERMES reported $11.09M in Interest Income for its fiscal quarter ending in June of 2025.


Interest Income Change Date
AbbVie USD 73M 19M Mar/2025
Acadia Pharmaceuticals USD 7.24M 658K Jun/2025
ALKERMES USD 11.09M 949K Jun/2025
Biogen USD 32.3M 8.4M Jun/2025
BioMarin Pharmaceutical USD 18.83M 186K Jun/2025
Eli Lilly USD 40M 8.3M Jun/2025
Gilead Sciences 73M 21M Jun/2025
Ionis Pharmaceuticals -0.66 0.29 Dec/2024
J&J 332M 51M Mar/2025
Merck USD 109M 37M Mar/2025
Otsuka Holdings 10.49B 396M Jun/2024
Pfizer USD 156M 13M Jun/2025
Regeneron Pharmaceuticals 174.8M 1.3M Jun/2025
Vertex Pharmaceuticals USD 122.4M 1.5M Jun/2025